22 March 2018
News and Views
Links and Services
A recent issue of the American Journal of Gastroenterology investigates atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease.
Nonalcoholic fatty liver disease (NAFLD) is defined as the spectrum of benign fatty liver to necr
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors